| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |